Equity
Cumulative Gross Losses and Impairments
Pfizer Cumulative Gross Losses and Impairments increased by 7.4% to $467.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 44.6%, from $323.00M to $467.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ3 2016
Last reportedQ3 2025
How to read this metric
A rising trend indicates persistent underperformance or market-wide stress affecting the firm's long-term holdings.
Detailed definition
This metric aggregates all unrealized losses and impairment charges on investments that have not yet been recognized in...
Peer comparison
Reported in equity or comprehensive income disclosures for firms with significant investment portfolios.
Metric ID:
cumulative_gross_losses_and_impairmentsHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $93.00M | $95.00M | $110.00M | $108.00M | $148.00M | $171.00M | $170.00M | $188.00M | $293.00M | $306.00M | $323.00M | $400.00M | $435.00M | $467.00M |
| QoQ Change | — | +2.2% | +15.8% | -1.8% | +37.0% | +15.5% | -0.6% | +10.6% | +55.9% | +4.4% | +5.6% | +23.8% | +8.8% | +7.4% |
| YoY Change | — | — | — | +16.1% | +55.8% | +55.5% | +57.4% | +27.0% | +71.3% | +80.0% | +71.8% | +36.5% | +42.2% | +44.6% |
Range$93.00M – $467.00M
CAGR+64.3%
Avg YoY Growth+50.7%
Median YoY Growth+55.5%
Current Streak7 quarters growth
Cumulative Gross Losses and Impairments at Other Companies
Frequently Asked Questions
- What is Pfizer's cumulative gross losses and impairments?
- Pfizer (PFE) reported cumulative gross losses and impairments of $467.00M in Q3 2025.
- How has Pfizer's cumulative gross losses and impairments changed year-over-year?
- Pfizer's cumulative gross losses and impairments increased by 44.6% year-over-year, from $323.00M to $467.00M.
- What does cumulative gross losses and impairments mean?
- The total amount of value lost on investments that hasn't been officially recorded as a loss on the income statement yet.